Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism

Cited by (807)

Items 201–300 of 807

1. Unprovoked Venous Thromboembolism: Short term or Indefinite Anticoagulation? Balancing Long-Term Risk and Benefit
   Marc Alan Rodger, Marc Carrier, Esteban Gándara, Grégoire Le Gal · 2010 · Blood Reviews
2. Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention
   Cynthia M. Wu, Ghazi Alotaibi, Khalid A. AlSaleh, Lori‐Ann Linkins, Michael Sean McMurtry · 2014 · Thrombosis Research
3. Sex-based disparities in venous thromboembolism outcomes: A National Inpatient Sample (NIS)-based analysis
   Ariela Lucy Marshall, Adam C. Bartley, Aneel A. Ashrani, Rajiv K. Pruthi, Urshila Durani, Wilson I. Gonsalves, Prashant Kapoor, Shahrukh Khurshid Hashmi, Mustaqeem Ahmad Siddiqui, Ronald S. Go · 2017 · Vascular Medicine
4. Incidence of venous thromboembolism in first-degree relatives of patients with venous thromboembolism who have factor V Leiden
   Clive Kearon, Christophe Leroyer, Bernard Mercier, Jean François Abgrall, Grégoire Le Gal, Karine Lacut, Emmanuel Oger, Luc Bressollette, Claude Férec, Michel P. Lamure et al. · 2006 · Thrombosis and Haemostasis
5. The Use of Pharmacoepidemiology to Study Beneficial Drug Effects
   Brian L. Strom, Kenneth L. Melmon · 2012 · Pharmacoepidemiology
6. Association between venous thromboembolism and plasma levels of both soluble fibrin and plasminogen-activator inhibitor 1 in 170 patients undergoing total hip arthroplasty
   Yohei Yukizawa, Yutaka Inaba, Shinichiro Watanabe, Satoshi Yajima, Naomi Kobayashi, Takashi Ishida, Naoyuki Iwamoto, Hyonmin Choe, Tomoyuki Saito · 2012 · Acta Orthopaedica
7. New anticoagulants for the treatment of venous thromboembolism
   Caio Júlio César dos Santos Fernandes, José Leonidas Alves, Francisca Gavilanes, Luis Felipe Prada, Luciana Tamie Kato Morinaga, Rogério Souza · 2016 · Jornal Brasileiro de Pneumologia
8. Importance of Device Evaluation for Point-of-Care Prothrombin Time International Normalized Ratio Testing Programs
   Robert D. McBane, Cindy L. Felty, Mindy L. Hartgers, Rajeev Chaudhry, Lisa K. Beyer, Paula J. Santrach · 2005 · Mayo Clinic Proceedings
9. Responsiveness to low-dose warfarin associated with genetic variants of VKORC1, CYP2C9, CYP2C19, and CYP4F2 in an Indonesian population
   Taofik Rusdiana, T. Araki, Tetsuya Nakamura, Anas Subarnas, Kazuyoshi Yamamoto · 2012 · European Journal of Clinical Pharmacology
10. Prevalence of factor V Leiden (G1691A) and prothrombin (G20210A) among Kurdish population from Western Iran
    Zohreh Rahimi, Asad Vaisi‐Raygani, Hadi Mozafari, Hadi Kharrazi, Mansour Rezaei, Ronald L. Nagel · 2007 · Journal of Thrombosis and Thrombolysis
11. Effects ofCYP2C9andVKORC1on INR Variations and dose Requirements During Initial Phase of Anticoagulant Therapy
    Marta Spreafico, Corrado Lodigiani, Y van Leeuwen, Denise Pizzotti, Lidia Luciana Rota, Frits Richard Rosendaal, Pier Mannuccio Mannucci, Flora Peyvandi · 2008 · Pharmacogenomics
12. Management of Venous Thromboembolisms: Part I. The Consensus for Deep Vein Thrombosis.
    Kang-Ling Wang, Pao Hsien Chu, Cheng‐Han Lee, Pei Ying Pai, Pao-Yen Lin, Kou Gi Shyu, Wei‐Tien Chang, Kuan‐Ming Chiu, Chien-Lung Huang, Chung Yi Lee et al. · 2016 · Europe PMC (PubMed Central)
13. Guía para el tratamiento preventivo del ictus isquémico y AIT (II). Recomendaciones según subtipo etiológico
    Blanca Fuentes, J. Gállego, Antonio Gil-Núñez, Ana Morales, Francisco F. Purroy, Jaume Roquer, Tomás Segura, Javier Tejada, Aida Pilar Lago, Exuperio Díez‐Tejedor et al. · 2011 · Neurología
14. Predictors of Venous Thromboembolism in Patients with Advanced Common Solid Cancers
    Isaac E. Hall, Martin S. Andersen, Harlan M. Krumholz, Cary Philip Gross · 2009 · Journal of Cancer Epidemiology
15. Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism
    C.J.J. van Dongen, Martin H. Prins, Harry Roger Buller · 2003 · New England Journal of Medicine
16. First-generation agents: aspirin, heparin and coumarins
    Richard L. Mueller · 2004 · Best Practice & Research Clinical Haematology
17. Prevention of Recurrent Deep Venous Thrombosis with Sulodexide: The SanVal Registry
    B.M. Errichi, Maria Rosaria Cesarone, GIANNI V. BELCARO, R. Marinucci, Andrea Ricci, Antonio Massimo Ippolito, R. Brandolini, G. Vinciguerra, Mark Dugall, A. Felicita et al. · 2004 · Angiology
18. Pregnancy-Associated Venous Thromboembolism: Prevention and Treatment
    Shannon M. Bates · 2011 · Seminars in Hematology
19. Direct-to-patient expert system and home INR monitoring improves control of oral anticoagulation
    Susan I. O’Shea, Murat O. Arcasoy, Gregory P. Samsa, Sandra E. Cummings, Elizabeth H. Thames, Richard S. Surwit, Thomas L. Ortel · 2007 · Journal of Thrombosis and Thrombolysis
20. Diagnosis and treatment of pediatric patients with late-onset portal vein stenosis after living donor liver transplantation
    Youichi Kawano, Koichi Mizuta, Yasuhiko Sugawara, Satoshi Egami, Shuji Hisikawa, Yukihiro Sanada, Takehito Fujiwara, Yasunaru Sakuma, Masanobu Hyodo, Yoshiyuki Yoshida et al. · 2009 · Transplant International
21. Measurement of free concentrations of highly protein-bound warfarin in plasma by ultra performance liquid chromatography–tandem mass spectrometry and its correlation with the international normalized ratio
    Chenrong Huang, Jian Yang, Yonghong Du, Liyan Miao · 2008 · Clinica Chimica Acta
22. Venous thromboembolism: diagnosis and management of pulmonary embolism
    Cindy H Lee, Graeme J. Hankey, Wai Khoon Ho, John W. Eikelboom · 2005 · The Medical Journal of Australia
23. New approaches to prevention of thrombosis in the antiphospholipid syndrome: Hopes, trials, and tribulations
    Robert A. S. Roubey · 2003 · Arthritis & Rheumatism
24. Cerebral Venous Sinus Thrombosis: Prevention of Recurrent Thromboembolism
    Bart F.L. van Nuenen, Marten Munneke, Bastiaan R. Bloem · 2005 · Stroke
25. The use of aspirin for primary and secondary prevention in venous thromboembolism and other cardiovascular disorders
    Alexander Thomas Cohen, Stephan Imfeld, J. Markham, Serena Granziera · 2014 · Thrombosis Research
26. DVT and pulmonary embolism: Part II. Treatment and prevention.
    Dino W Ramzi, Kenneth V. Leeper · 2004 · PubMed
27. Venous thromboembolism: Predicting recurrence and the need for extended anticoagulation
    Geoffrey D. Barnes, Yogendra M. Kanthi, James B. Froehlich · 2015 · Vascular Medicine
28. Long-term clinical course of acute pulmonary embolism
    Paul L. den Exter, Tom van der Hulle, Mareike Lankeit, Menno Volkert Huisman, Frederikus Albertus Klok · 2013 · Blood Reviews
29. Management of Venous Thromboembolism in the Elderly
    Alex C. Spyropoulos, Geno J. Merli · 2006 · Drugs & Aging
30. A review of the oral direct thrombin inhibitor ximelagatran
    Robert Mohapatra, Maichi T. Tran, Joel M. Gore, Frederick A. Spencer · 2005 · American Heart Journal
31. Thrombophilia testing in people with venous thromboembolism: systematic review and cost-effectiveness analysis
    Emma L. Simpson, Matt Stevenson, Andrew Rawdin, Diana E. Papaioannou · 2009 · Health Technology Assessment
32. The management of thromboembolic disease in patients with central nervous system malignancies
    Mary Ann Knovich, Glenn Jay Lesser · 2004 · Current Treatment Options in Oncology
33. Extended anticoagulation for the secondary prevention of venous thromboembolic events: An updated network meta-analysis
    Vicky Mai, Laurent Bertoletti, Michel Cucherat, Sabine Mainbourg, C. Grangé, Steeve Provencher, Jean‐Christophe Lega · 2019 · PLoS ONE
34. Extended Anticoagulation for VTE
    Vicky Mai, Charles-Antoine Guay, Laurie Perreault, Sébastien Bonnet, Laurent Bertoletti, Yves Lacasse, Sabine Mainbourg, Jean‐Christophe Lega, Steeve Provencher · 2019 · CHEST Journal
35. Prevalence and the clinical outcome of atrial fibrillation in patients with Autoimmune Rheumatic Disease
    Yong‐Soo Baek, Tae‐Hoon Kim, Jae‐Sun Uhm, Jong‐Youn Kim, Hui‐Nam Pak, Moon‐Hyoung Lee, Boyoung Joung · 2016 · International Journal of Cardiology
36. Oral Anticoagulation and Risk of Adverse Clinical Outcomes in Venous Thromboembolism
    Sungho Bea, Geetha S. Iyer, Dae‐Hyun Kim, Kueiyu Joshua Lin, Yichi Zhang, Heidi Zakoul, Helen Tesfaye, Katsiaryna Bykov · 2025 · JAMA Internal Medicine
37. Incidence and Risk Factors of the Post-thrombotic Syndrome
    Mark A. Wolf, Cees H.A. Wittens, Susan Rebecca Kahn · 2012 · Phlebology The Journal of Venous Disease
38. Therapeutic Strategy for Gastrointestinal Bleeding in Patients With Left Ventricular Assist Device
    Teruhiko Imamura, Koichiro Kinugawa, Nir Y. Uriel · 2018 · Circulation Journal
39. Deadly drug interactions in emergency medicine
    Katherine M. Prybys · 2004 · Emergency Medicine Clinics of North America
40. Low-dose warfarin in atrial fibrillation leads to more thromboembolic events without reducing major bleeding when compared to adjusted-dose
    Christine Perret‐Guillaume, Denis G. Wahl · 2003 · Thrombosis and Haemostasis
41. Optimal Duration of Anticoagulation After Venous Thromboembolism
    Samuel Zachary Goldhaber, Gregory Piazza · 2011 · Circulation
42. Thrombophilia: Clinical and Laboratory Assessment and Management
    John A. Heit · 2007 · Elsevier eBooks
43. Pharmacogenetics and Anticoagulant Therapy
    Brian F. Gage, Charles S. Eby · 2003 · Journal of Thrombosis and Thrombolysis
44. Thromboembolism—Another Threat to the Polymorbid Patient with Vasculitis?
    Peter A. Merkel, G K Lo, J H Holbrook, Andrea K. Tibbs, Allen Nb, J C Davis, Gary Stuart Hoffman, W. Joseph McCune, E. W. St. Clair, Ulrich Specks et al. · 2005 · Journal of the American Society of Nephrology
45. Oral anticoagulation strategies after a first idiopathic venous thromboembolic event
    Aujesky, Drahomir, Smith, Kenneth J., Roberts, Mark S. · 2005 · The American Journal of Medicine
46. Perioperative Management of Oral Anticoagulation
    Martin James O'Donnell, Clive Kearon · 2008 · Cardiology Clinics
47. Risk Factors for Venous Thromboembolism in Nursing Home Residents
    Cynthia L. Leibson, Tanya M. Petterson, Kent R. Bailey, L. Joseph Melton, John A. Heit · 2008 · Mayo Clinic Proceedings
48. Duration of Anticoagulation Therapy for Venous Thromboembolism
    Henri Bounameaux, Arnaud Perrier · 2008 · Hematology
49. Patient Self-Management of Oral Anticoagulation with Vitamin K Antagonists in Everyday Practice: Efficacy and Safety in a Nationwide Long-Term Prospective Cohort Study
    Michael Nagler, Lucas M. Bachmann, Pirmin Schmid, Pascale Raddatz Müller, Walter Alfred Wuillemin · 2014 · PLoS ONE
50. Low-molecular weight heparin for deep vein thrombosis prophylaxis in hospitalized medical patients: results from a cost-effectiveness analysis
    Andrew F. Shorr, William L. Jackson, Brendan M. Weiss, Lisa K. Moores · 2007 · Blood Coagulation & Fibrinolysis
51. Declining Long-term Risk of Adverse Events after First-time Community-presenting Venous Thromboembolism: The Population-based Worcester VTE Study (1999 to 2009)
    Wei Huang, Robert Joel Goldberg, A.T. Cohen, Fred A. Anderson, Catarina I. Kiefe, Joel M. Gore, Frederick Alan Spencer · 2015 · Thrombosis Research
52. Extended anticoagulation after venous thromboembolism: should it be done?
    Caio Júlio César dos Santos Fernandes, Daniela Calderaro, Bruna Mamprim Piloto, Susana Hoette, Carlos Jardim, Rogério Souza · 2019 · Therapeutic Advances in Respiratory Disease
53. Warfarin for Refractory Chronic Cluster Headache: A Randomized Pilot Study
    Sameh Michel Hakim · 2011 · Headache The Journal of Head and Face Pain
54. What is the Optimal Duration of Treatment for DVT? An Update on Evidence-Based Medicine of Treatment for DVT
    Andrea T. East, Thomas W. Wakefield · 2010 · Seminars in Vascular Surgery
55. Thromboembolic Diseases
    Thomas W. Wakefield, Joseph A. Caprini, Anthony James Comerota · 2008 · Current Problems in Surgery
56. Indefinite anticoagulation after a first episode of unprovoked venous thromboembolism: yes
    Clive Kearon · 2007 · Journal of Thrombosis and Haemostasis
57. Duration of anticoagulant therapy for venous thromboembolism: balancing benefits and harms on the long term
    Paulien G. de Jong, Michiel Coppens, Saskia Middeldorp · 2012 · British Journal of Haematology
58. New concepts in optimal management of anticoagulant therapy for extended treatment of venous thromboembolism
    Mats Ögren, Sam Schulman · 2006 · Thrombosis and Haemostasis
59. Risk factors for predicting venous thromboembolism in patients with nephrotic syndrome: focus on haemostasis-related parameters
    Gener Ismail, Gabriel Mircescu, Alecse Valerian Ditoiu, Beatrice Dorina Tacu, Roxana A. Jurubiță, Mihai Hârza · 2013 · International Urology and Nephrology
60. Comparative performance of warfarin pharmacogenetic algorithms in Chinese patients
    Yu Liu, Jie Yang, Qiang Xu, Bin Xu, Lei Gao, Yuxiao Zhang, Yan Zhang, Hongjuan Wang, Caiyi Lu, Yusheng Zhao et al. · 2012 · Thrombosis Research
61. Low-Intensity versus Conventional-Intensity Warfarin for Prevention of Recurrent Venous Thromboembolism
    Menno V Huisman, Felix J M van der Meer, Cornelis J van Rooden, Martin H. Prins · 2003 · New England Journal of Medicine
62. Risk of thromboembolism after cerebral venous thrombosis
    Vicky Maqueda, Vincent Thijs · 2006 · European Journal of Neurology
63. Current Issues in Anticoagulation
    Giancarlo Agnelli · 2005 · Pathophysiology of Haemostasis and Thrombosis
64. Unresolved issues in anticoagulant therapy
    Sam Schulman · 2003 · Journal of Thrombosis and Haemostasis
65. How Fragile Are Clinical Trial Outcomes That Support the CHEST Clinical Practice Guidelines for VTE?
    Elizabeth A. Edwards, Cole Wayant, Jonathan Besas, Justin Chronister, Matt B. Vassar · 2018 · CHEST Journal
66. Studies on Atrial Fibrillation and Venous Thromboembolism in the Past 20 Years: A Bibliometric Analysis Via CiteSpace and VOSviewer
    Lina Miao, Junhe Shi, Haixu Yu, Lei Song, Chunlin Zhu, Dazhuo Shi, Jie Gao · 2023 · Journal of the American Heart Association
67. Major bleeding during secondary prevention of venous thromboembolism in patients who have completed anticoagulation: a systematic review and meta‐analysis
    Lana A. Castellucci, Grégoire Le Gal, Marc Alan Rodger, Marc Carrier · 2014 · Journal of Thrombosis and Haemostasis
68. The risk of recurrent thromboembolic disorders in patients with unprovoked venous thromboembolism: New scenarios and opportunities
    Paolo Prandoni, Sofia Barbar, Marta Milan, Valentina Vedovetto, Raffaele Pesavento · 2013 · European Journal of Internal Medicine
69. Anticoagulant effects of Idraparinux after termination of therapy for prevention of recurrent venous thromboembolism: observations from the van Gogh trials
    Job Harenberg, Ingrid Jörg, Yvonne Vukojevic, Gerd Mikus, Christel Weiß · 2008 · European Journal of Clinical Pharmacology
70. Beyond Virchow’s Triad: Does cardiovascular inflammation explain the recurrent nature of venous thromboembolism?
    Gregory Piazza · 2015 · Vascular Medicine
71. Derivation of the non-inferiority margin for the evaluation of direct oral anticoagulants in the treatment of venous thromboembolism
    Martin H. Prins, Anthonie W.A. Lensing · 2013 · Thrombosis Journal
72. Quality use of generic medicines
    Mohamed Azmi Hassali, Kay Stewart, David C. M. Kong · 2004 · Australian Prescriber
73. An Update on the Management of Chronic Thromboembolic Pulmonary Hypertension
    Justin A. Edward, Stacy A. Mandras · 2016 · Current Problems in Cardiology
74. Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism
    Lindsay Robertson, Su Ern Yeoh, Ahmad Hariz Ramli · 2017 · Cochrane Database of Systematic Reviews
75. Pulmonary embolism and pregnancy
    Sarah E. Stone, Timothy A. Morris · 2004 · Critical Care Clinics
76. Thrombolytic Therapy for Massive Pulmonary Embolism in a Patient With a Known Intracranial Tumor
    Steve Han, Craig Chaya, Guy W. Soo Hoo · 2006 · Journal of Intensive Care Medicine
77. Low-Dose Warfarin for Prevention of Symptomatic Thromboembolism after Orthopedic Surgery
    Jeremy J Enyart, Ronald J Jones · 2005 · Annals of Pharmacotherapy
78. Anticoagulation monitoring by an anticoagulation service is more cost-effective than routine physician care
    Faisal Aziz, M. Corder, Jaclyn Wolffe, Anthony James Comerota · 2011 · Journal of Vascular Surgery
79. The Use of Warfarin for DVT Prophylaxis Following Hip and Knee Arthroplasty: How Often Are Patients Within Their Target INR Range?
    Denis Nam, Anita Sadhu, Jeffrey B. Hirsh, James A. Keeney, Ryan M. Nunley, Robert L. Barrack · 2014 · The Journal of Arthroplasty
80. Strategy to prevent recurrent portal vein stenosis following interventional radiology in pediatric liver transplantation
    Yukihiro Sanada, Youichi Kawano, Koichi Mizuta, Satoshi Egami, Makoto Hayashida, Taiichi Wakiya, Takehito Fujiwara, Yasunaru Sakuma, Masanobu Hydo, Manabu Nakata et al. · 2010 · Liver Transplantation
81. Inherited Thrombophilia: Key Points for Genetic Counseling
    Elizabeth Varga · 2007 · Journal of Genetic Counseling
82. Venous Thromboembolic Events in the Rehabilitation Setting
    Brian M. Kelly, Brian Yoder, Chi‐Tsai Tang, Thomas W. Wakefield · 2010 · PM&R
83. Prognostic factors for recurrence of venous thromboembolism (VTE) or bleeding during long-term secondary prevention of VTE with ximelagatran
    Torbjörn Lundström, Karin Wåhlander, Solveig Billing Clason, Sam Schulman, Henry Eriksson, for the THRIVE III Investigators · 2005 · Thrombosis and Haemostasis
84. DVT Prevention: What Is Happening in the “Real World”?
    Samuel Zachary Goldhaber · 2003 · Seminars in Thrombosis and Hemostasis
85. Guidelines for the preventive treatment of ischaemic stroke and TIA (II). Recommendations according to aetiological sub-type
    Blanca Fuentes, J. Gállego, Antonio Gil-Núñez, Ana Morales, Francisco F. Purroy, Jaume Roquer, Tomás Segura, Javier Tejada, Aida Pilar Lago, Exuperio Díez‐Tejedor et al. · 2014 · Neurología (English Edition)
86. Duration of Anticoagulation After Cerebral Venous Sinus Thrombosis
    Frances Caprio, Richard A. Bernstein · 2011 · Neurocritical Care
87. CLIA-tested genetic variants on commercial SNP arrays: Potential for incidental findings in genome-wide association studies
    Andrew D. Johnson, Anupama Bhimavarapu, Emelia J. Benjamin, Caroline S. Fox, Daniel A Levy, Gail Pairitz Jarvik, Christopher J. O’Donnell · 2010 · Genetics in Medicine
88. Pulmonary Hypertension in the Critical Care Setting: Classification, Pathophysiology, Diagnosis, and Management
    Melvyn Rubenfire, Melike Bayram, Zachary Hector-Word · 2007 · Critical Care Clinics
89. Update on extended treatment for venous thromboembolism
    Eduardo Peñaloza-Martínez, Pablo Demelo Rodríguez, Marco Proietti, Guillermo Soria Fernández‐Llamazares, Cristina Llamazares Mendo, José Luis Álvarez-Sala, Alberto Maria Marra, Jorge del Toro‐Cervera · 2018 · Annals of Medicine
90. Genetic risk factors in recurrent venous thromboembolism: A multilocus, population-based, prospective approach
    Robert Y.L. Zee, Vadim Y. Bubes, Sanjay Shrivastava, Paul M. Ridker, Robert J. Glynn · 2009 · Clinica Chimica Acta
91. DVT: A New Era in Anticoagulant Therapy
    Nigel Mackman, Richard Clinton Becker · 2010 · Arteriosclerosis Thrombosis and Vascular Biology
92. Bleeding and clotting in hereditary hemorrhagic telangiectasia
    Christopher E. Dittus · 2015 · World Journal of Clinical Cases
93. Management of immobilization and its complication for elderly.
    Purwita Wijaya Laksmi, Kuntjoro Harimurti, Siti Setiati, Czeresna Heriawan Soejono, Wanarani Aries, Arya Govinda Roosheroe · 2008 · PubMed
94. Ximelagatran: An orally active direct thrombin inhibitor
    Michael P. Gulseth · 2005 · American Journal of Health-System Pharmacy
95. Long‐term low‐dose warfarin use is effective in the prevention of recurrent venous thromboembolism: yes
    Paul M. Ridker · 2004 · Journal of Thrombosis and Haemostasis
96. Vitamin K and oral anticoagulation: thought for food
    Edwin G. Bovill, Mark K.Y. Fung, Mary Cushman · 2004 · The American Journal of Medicine
97. Outcomes of genetic testing in adults with a history of venous thromboembolism.
    Jodi B Segal, Daniel J. Brotman, Ashkan Emadi, Alejandro J Necochea, Lipika Samal, Lisa M Wilson, Matthew T Crim, Eric B Bass · 2009 · PubMed Central
98. Broadening the Categories of Patients Eligible for Extended Venous Thromboembolism Treatment
    Marc Schindewolf, Jeffrey Ian Weitz · 2019 · Thrombosis and Haemostasis
99. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden
    Jérôme Duchemin, Christophe Leroyer, Benedicte Delahousse, Jean François Abgrall, Dominique Mottier, Françis Couturaud, for the Groupe d’Etude de la Thrombose de Bretagne Occidentale (G.E.T.B.O) · 2007 · Thrombosis and Haemostasis
100. Balancing risks and benefits of extended anticoagulant therapy for idiopathic venous thrombosis
     Clive Kearon · 2009 · Journal of Thrombosis and Haemostasis